Shares of Rapid Micro Biosystems, Inc. (RPID) are up by 13.76% at $1.24 in premarket trading Wednesday, following the release of its preliminary unaudited financial results for the fourth quarter and full year 2024.
For the fourth quarter of 2024, the company expects total revenue to be approximately $8.2 million, a 30% growth year-over-year, and slightly above Wall Street analysts' consensus estimate of $7.6 million.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.